Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-29-13 | Dec-30-12 | Jan-01-12 | Jan-02-11 | Jan-03-10 | Dec-28-08 | Dec-30-07 | Dec-31-06 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Business Solutions | 489.7 | 386.1 | 411.3 | 417.4 | | | | |
| Healthcare | 230.1 | 215.9 | 236.8 | 251.0 | | | | |
| Total revenues [+] | 719.8 | 602.0 | 648.1 | 668.4 | 694.0 | 791.1 | 865.4 | 894.3 |
| Products | 619.2 | 528.8 | 560.6 | 573.3 | 594.1 | | | |
| Services | 100.6 | 73.2 | 87.5 | 95.1 | 99.9 | | | |
| Revenue growth [+] | 19.6% | -7.1% | -3.0% | -3.7% | -12.3% | -8.6% | -3.2% | 0.5% |
| Business Solutions | 26.8% | -6.1% | -1.5% | | | | | |
| Healthcare | 6.6% | -8.8% | -5.7% | | | | | |
| Cost of goods sold [+] | 513.3 | 421.6 | 449.9 | 458.6 | 478.4 | 540.3 | 593.1 | 602.9 |
| Cost of product sales | 452.7 | 378.8 | 396.1 | 398.3 | 414.8 | | | |
| Cost of services | 60.6 | 42.8 | 53.9 | 60.3 | 63.6 | | | |
| Gross profit | 206.5 | 180.4 | 198.2 | 209.8 | 215.6 | 250.8 | 272.3 | 291.4 |
| Gross margin | 28.7% | 30.0% | 30.6% | 31.4% | 31.1% | 31.7% | 31.5% | 32.6% |
| Selling, general and administrative | 182.9 | 200.4 | 245.1 | 203.8 | 205.3 | 228.3 | 252.2 | 276.2 |
| Research and development | | | | | | | | |
| Other operating expenses | | | -20.2 | 0.4 | 22.9 | 0.1 | 21.8 | |
| EBITDA [+] | 50.6 | 2.0 | -4.9 | 28.9 | 12.5 | 49.0 | 25.1 | 46.2 |
| EBITDA growth | 2461.8% | -140.3% | -117.0% | 131.1% | -74.5% | 95.0% | -45.6% | -26.9% |
| EBITDA margin | 7.0% | 0.3% | -0.8% | 4.3% | 1.8% | 6.2% | 2.9% | 5.2% |
| Depreciation and amortization | 27.1 | 22.0 | 21.8 | 23.3 | 25.0 | 26.5 | 26.8 | 31.0 |
| EBIT [+] | 23.5 | -20.0 | -26.7 | 5.6 | -12.5 | 22.5 | -1.6 | 15.2 |
| EBIT growth | -217.5% | -25.0% | -574.5% | -144.9% | -155.9% | -1466.8% | -110.8% | -36.6% |
| EBIT margin | 3.3% | -3.3% | -4.1% | 0.8% | -1.8% | 2.8% | -0.2% | 1.7% |
| Non-recurring items [+] | 26.5 | 5.3 | 5.2 | 1.7 | 12.7 | 5.8 | 7.6 | 5.4 |
| Asset impairment | 1.3 | | | | 1.2 | 0.2 | -0.4 | 2.7 |
| Restructuring charges | 25.2 | 5.3 | 5.2 | 1.7 | 11.5 | | | |
| Interest expense | 9.9 | 2.7 | 2.5 | 2.2 | 1.2 | 2.2 | 3.8 | 2.3 |
| Interest expense | 9.9 | 2.7 | 2.5 | 2.2 | 1.2 | 2.2 | 3.8 | 2.3 |
| Other income (expense), net [+] | 0.1 | 0.0 | 0.6 | -0.3 | 0.4 | 0.3 | 0.2 | 0.2 |
| Environmental remediation expense | 0.0 | 0.4 | 0.2 | -0.8 | 2.5 | | | |
| Other | 0.1 | 0.4 | 0.6 | -1.1 | 2.9 | | | |
| Pre-tax income | -12.8 | -27.9 | -33.7 | 1.4 | -26.0 | 14.7 | -12.8 | 7.7 |
| Income taxes | -5.3 | 0.5 | 91.7 | 1.0 | -10.7 | 7.9 | -5.2 | 4.5 |
| Tax rate | 41.9% | | | 73.2% | 41.0% | 53.6% | 40.6% | 58.2% |
| Earnings from continuing ops | -7.4 | -28.5 | -125.4 | 0.4 | -15.4 | 6.8 | -7.6 | 3.2 |
| Earnings from discontinued ops | | | | | | 6.8 | 0.0 | 0.0 |
| Net income | -7.4 | -28.5 | -125.4 | 0.4 | -15.4 | 13.7 | -7.3 | 3.2 |
| Net margin | -1.0% | -4.7% | -19.4% | 0.1% | -2.2% | 1.7% | -0.8% | 0.4% |
| |
| Basic EPS [+] | ($1.16) | ($4.88) | ($21.59) | $0.01 | ($0.53) | $3,416.75 | ($7,579.00) | $3,227.00 |
| Growth | -76.2% | -77.4% | -169745.0% | -102.4% | -100.0% | -145.1% | -334.9% | -68.8% |
| Diluted EPS [+] | ($1.16) | ($4.88) | ($21.59) | $0.01 | ($0.53) | $0.12 | ($0.26) | $0.11 |
| Growth | -76.2% | -77.4% | -169903.4% | -102.4% | -541.8% | -146.2% | -330.1% | -100.0% |
| |
| Dividends per share [+] | | $0.26 | $1.00 | $0.20 | $0.38 | | | |
| Growth | -100.0% | -74.4% | 400.2% | -47.2% | | | | |
| |
| Shares outstanding (basic) [+] | 6.4 | 5.8 | 5.8 | 28.9 | 29.0 | 0.0 | 0.0 | 0.0 |
| Growth | 9.4% | 0.5% | -79.9% | -0.2% | 1449864.2% | 99.9% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 6.4 | 5.8 | 5.8 | 28.9 | 29.0 | 56.9 | 29.2 | 28.6 |
| Growth | 9.4% | 0.5% | -79.9% | -0.2% | -49.1% | 94.9% | 2.1% | 102205.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|